Bradley S. Galer

Chief Medical Officer, Zogenix (United States).

Companies

Rapport Therapeutics, Inc.Chief Medical Officer Jun 6, 2024 to Jun 10, 2024¹
Zogenix (United States)Chief Medical Officer Dec 18, 2013 to Mar 9, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Rapport Therapeutics, Inc. RAPP197,426 shares³$5.7M at $28.65Jun 6, 2024
Zogenix (United States)0 shares⁴Mar 7, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 7, 2022U 25,022 shares of Zogenix (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRapport Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARZogenix (United States), Chief Medical Officer
3
SEC EDGARRapport Therapeutics, Inc. shares after the filing of Jun 6, 2024
4
SEC EDGARZogenix (United States) shares after the filing of Mar 7, 2022